van Wering ER - Search Results

1

CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia.

van Grotel M, van den Heuvel-Eibrink MM, van Wering ER, van Noesel MM, Kamps WA, Veerman AJ, Pieters R, Meijerink JP. van Grotel M, et al. Among authors: van den heuvel eibrink mm, van noesel mm, van wering er. Pediatr Blood Cancer. 2008 Dec;51(6):737-40. doi: 10.1002/pbc.21707. Pediatr Blood Cancer. 2008. PMID: 18683236

2

Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.

Stams WA, den Boer ML, Beverloo HB, Meijerink JP, Stigter RL, van Wering ER, Janka-Schaub GE, Slater R, Pieters R. Stams WA, et al. Among authors: van wering er. Blood. 2003 Apr 1;101(7):2743-7. doi: 10.1182/blood-2002-08-2446. Epub 2002 Nov 14. Blood. 2003. PMID: 12433682 Free article.

3

Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

Stams WA, den Boer ML, Holleman A, Appel IM, Beverloo HB, van Wering ER, Janka-Schaub GE, Evans WE, Pieters R. Stams WA, et al. Among authors: van wering er. Blood. 2005 Jun 1;105(11):4223-5. doi: 10.1182/blood-2004-10-3892. Epub 2005 Feb 17. Blood. 2005. PMID: 15718422 Free article.

4

Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.

Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R. Stams WA, et al. Among authors: van wering er. Clin Cancer Res. 2005 Apr 15;11(8):2974-80. doi: 10.1158/1078-0432.CCR-04-1829. Clin Cancer Res. 2005. PMID: 15837750

5

Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.

Tissing WJ, Meijerink JP, den Boer ML, Brinkhof B, van Rossum EF, van Wering ER, Koper JW, Sonneveld P, Pieters R. Tissing WJ, et al. Among authors: van wering er, van rossum ef. Clin Cancer Res. 2005 Aug 15;11(16):6050-6. doi: 10.1158/1078-0432.CCR-04-2097. Clin Cancer Res. 2005. PMID: 16115950

6

The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.

Van Vlierberghe P, van Grotel M, Beverloo HB, Lee C, Helgason T, Buijs-Gladdines J, Passier M, van Wering ER, Veerman AJ, Kamps WA, Meijerink JP, Pieters R. Van Vlierberghe P, et al. Among authors: van grotel m, van wering er. Blood. 2006 Nov 15;108(10):3520-9. doi: 10.1182/blood-2006-04-019927. Epub 2006 Jul 27. Blood. 2006. PMID: 16873670 Free article.

7

The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.

van Grotel M, Meijerink JP, Beverloo HB, Langerak AW, Buys-Gladdines JG, Schneider P, Poulsen TS, den Boer ML, Horstmann M, Kamps WA, Veerman AJ, van Wering ER, van Noesel MM, Pieters R. van Grotel M, et al. Among authors: van noesel mm, van wering er. Haematologica. 2006 Sep;91(9):1212-21. Haematologica. 2006. PMID: 16956820

8

Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.

Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, Zwaan CM, Van den Heuvel-Eibrink MM, Meijerink JP. Balgobind BV, et al. Among authors: van den heuvel eibrink mm, van den ouweland am, van wering er, van vlierberghe p. Blood. 2008 Apr 15;111(8):4322-8. doi: 10.1182/blood-2007-06-095075. Epub 2008 Jan 2. Blood. 2008. PMID: 18172006 Free article.

9

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.

Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo HB, van der Spek PJ, Stubbs A, Cools J, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering ER, Soulier J, Pieters R, Meijerink JP. Van Vlierberghe P, et al. Among authors: van grotel m, van der spek pj, van wering er. Blood. 2008 May 1;111(9):4668-80. doi: 10.1182/blood-2007-09-111872. Epub 2008 Feb 25. Blood. 2008. PMID: 18299449 Free PMC article.

10

Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.

Appel IM, Kazemier KM, Boos J, Lanvers C, Huijmans J, Veerman AJ, van Wering E, den Boer ML, Pieters R. Appel IM, et al. Leukemia. 2008 Sep;22(9):1665-79. doi: 10.1038/leu.2008.165. Epub 2008 Jun 26. Leukemia. 2008. PMID: 18580955 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters